Literature DB >> 19393952

H5N1 influenza vaccination policy in Japan.

Michiaki Masuda, Shigeo Sugita, Kazumichi Kuroda, Hidekazu Nishimura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19393952     DOI： 10.1016/S1473-3099(09)70106-9

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  4 in total

1.  Telephone monitoring of adverse events during an MF59®-adjuvanted H5N1 influenza vaccination campaign in Taiwan.

Authors:  Wan-Ting Huang; Chih-Hsi Chang; Mei-Chen Peng
Journal:  Hum Vaccin Immunother       Date:  2013-10-08       Impact factor: 3.452

2.  A phase II, open-label, multicentre study to evaluate the immunogenicity and safety of an adjuvanted prepandemic (H5N1) influenza vaccine in healthy Japanese adults.

Authors:  Hideaki Nagai; Hideyuki Ikematsu; Kazuyoshi Tenjinbaru; Atsushi Maeda; Mamadou Dramé; François P Roman
Journal:  BMC Infect Dis       Date:  2010-11-25       Impact factor: 3.090

Review 3.  A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region.

Authors:  Gina Samaan; Michelle McPherson; Jeffrey Partridge
Journal:  PLoS One       Date:  2013-07-16       Impact factor: 3.240

4.  Comprehensive Analysis of Antibodies Induced by Vaccination with 4 Kinds of Avian Influenza H5N1 Pre-Pandemic Vaccines.

Authors:  Nobuko Ohshima; Yoshitaka Iba; Ritsuko Kubota-Koketsu; Ayami Yamasaki; Keiko Majima; Gene Kurosawa; Daisuke Hirano; Shunji Yoshida; Mototaka Sugiura; Yoshizo Asano; Yoshinobu Okuno; Yoshikazu Kurosawa
Journal:  Int J Mol Sci       Date:  2020-10-08       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.